West Pharmaceutical Services generated $3.2B in trailing twelve-month revenue, up 0.1% year-over-year. Net income was $542.7M with a 16.85% net margin. Gross margin stands at 36.28% and operating margin at 20.34%. Diluted EPS is $7.48, which grew 0.2% year-over-year. Based on the Q1 2026 filing.